Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1756 USD | -0.62% | +0.40% | -18.78% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 44.04M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.6
x | P/E ratio 2025 * |
-1.6
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | -0.62% | ||
1 week | +0.40% | ||
Current month | -5.44% | ||
1 month | -15.98% | ||
3 months | -16.34% | ||
6 months | -17.64% | ||
Current year | -18.78% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.1756 | -0.62% | 1,285,443 |
24-05-09 | 0.1767 | -0.45% | 610,350 |
24-05-08 | 0.1775 | +3.80% | 570,695 |
24-05-07 | 0.171 | +1.79% | 538,023 |
24-05-06 | 0.168 | -3.95% | 1,526,471 |
Delayed Quote Nyse, May 10, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.78% | 44.04M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MTNB Stock